Takeda benadrukt de positieve punten voor volwassen ADHD-patiënten in de nieuwe 'V is for Vyvanse'-campagn

Takeda benadrukt de positieve punten voor volwassen ADHD-patiënten in de nieuwe 'V is for Vyvanse'-campagn

september 18, 2020 0 Door admin

Translating…


CBD Olie kan helpen bij ADHD. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec TDAH. Visite HuileCBD.be


 

Think the organizing fad with its attention to detail isn’t for people with attention deficit hyperactivity disorder? Takeda Pharmaceuticals wants to prove that wrong with a new branded DTC campaign.

Its new “V is for Vyvanse” campaign shows what adults with ADHD can achieve, such as focusing well enough to organize clothes by color.

Playing on the acronym aspect of  ADHD, the effort uses letters of the alphabet to describe symptom control in a positive fashion. With simple visuals and upbeat music, the ads invite people to “Rethink ADHD.”

Virtual Roundtable

ESMO Post Show: Highlights from the Virtual Conference

Cancer experts and pharma execs will break down the headline-making data from ESMO, sharing their insights and analysis around the conference’s most closely watched studies. This discussion will examine how groundbreaking research unveiled over the weekend will change clinical practice and prime drugs for key new indications, and panelists will fill you in on the need-to-know takeaways from oncology’s hottest fields. Register today.

Videos on Facebook and Instagram show how Vyvanse helps with core ADHD symptoms. For instance, inattention is addressed with “F is for better focused” with a rainbow organizer. Impulsivity is countered by “I for less impulsive,” which shows a man calmly and thoughtfully setting a table for dinner.

RELATED: Takeda whittles away costs—and assets—to keep its debt-cutting promises

The campaign is rooted in Takeda research with 1,200 patients. That work yielded a key insight—that people with ADHD shut down or disengage when they’re reminded how the condition affects their lives, said Kristie Whitehouse, Takeda’s director of consumer marketing for its neurodevelopment franchise, in an email interview.

“We set out to tell a different kind of story that empowered patients to see their symptoms in a more positive light,” she said.

While people often equate ADHD as a condition in children, Takeda is targeting adult patients with this campaign.

“Although ADHD is one of the most common neurobehavioral conditions among children in the U.S., it is not as widely recognized in adults. As a result, an estimated 6 million adults in the U.S. with ADHD go undiagnosed and therefore, do not receive the support they need,” Whitehouse said.

RELATED: FDA clears its first prescription video game treatment for ADHD

Another common ADHD symptom, hyperactivity, is addressed in a pre-roll ad running on websites including YouTube, WebMD and ADDitude. It includes a voiceover and speaking parts by actors portraying “the focused woman” and the “less impulsive man,” along with a studious-looking “less hyper” woman who says: “Tuesdays are great, because I have my two favorite seminars back to back.”

Vyvanse was approved to treat ADHD in adolescents in 2007 and in adults in 2008 under Shire, which merged with Takeda last year. It was also approved to treat moderate to severe binge eating disorder in adults in 2015. Through patent extension grants, Vyvanse remains protected from generic competition until 2023.


CBD Olie kan helpen bij ADHD. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec TDAH. Visite HuileCBD.be


 
Lees meer